Unadjusted model β (95% CI) | Minimally adjusted model β (95% CI) | Fully adjusted model β (95% CI) | |
---|---|---|---|
Per 1 μmol/L increase | −2.3 (−7.8, 3.3) | −6.1 (− 11.6, − 0.6)* | −7.4 (− 14.0, − 0.8)* |
Stratified by sex | |||
Men | 2.2 (− 5.6, 10.0) | − 2.3 (− 9.9, 5.3) | 1.7 (− 7.6, 11.0) |
LnBCL (Quartile) | |||
Q1 | Reference | Reference | Reference |
Q2 | − 6.3 (− 25.4, 12.7) | −11.4 (− 29.9, 7.1) | − 7.6 (− 26.3, 11.1) |
Q3 | −22.0 (− 40.3, − 3.6) | −27.0 (− 45.0, − 9.0) | −22.6 (− 41.8, − 3.4) |
Q4 | 7.3 (− 12.1, 26.7) | −4.3 (− 23.2, 14.7) | 3.3 (− 19.7, 26.3) |
P for trend | 0.927 | 0.234 | 0.550 |
Women | −10.4 (− 18.3, − 2.6)** | −12.2 (− 20.0, − 4.3)** | −18.7 (− 28.0, − 9.5)*** |
LnBCL (Quartile) | |||
Q1 | Reference | Reference | Reference |
Q2 | −4.1 (− 22.1, 13.9) | −3.1 (− 21.0, 14.7) | − 5.8 (− 23.6, 12.1) |
Q3 | 4.6 (− 12.8, 22.0) | 6.9 (− 10.5, 24.3) | 0.9 (− 16.8, 18.6) |
Q4 | − 20.6 (− 38.9, − 2.3) | − 23.6 (− 41.9, − 5.3) | − 36.5 (− 57.3, − 15.7) |
P for trend | 0.101 | 0.062 | 0.009 |